2,6-dimethyloctane-1,8-dioic acid: metabolite of phytanic acid; found in patients suffering from Refsum's disease [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 193373 |
| CHEBI ID | 180323 |
| SCHEMBL ID | 14360231 |
| MeSH ID | M0112984 |
| Synonym |
|---|
| 2,6-dimethyl-1,8-octanedioic acid |
| CHEBI:180323 |
| 3269-74-7 |
| 2,6-dimethyloctanedioic acid |
| LMFA01170129 |
| bms-197564 |
| 2,6-dmoa |
| 2,6-dimethyloctane-1,8-dioic acid |
| octanedioic acid, 2,6-dimethyl- |
| bms 197564 |
| SCHEMBL14360231 |
| DTXSID00954377 |
| Class | Description |
|---|---|
| medium-chain fatty acid | Any fatty acid with a chain length of between C6 and C12. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (20.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 1 (20.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 3 (60.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||